
( (S 
    (NP-SBJ-3 
      (NP (DT The) (NN amount) )
      (PP (IN of) 
        (NP 
          (NP (NN blood) )
          (SBAR 
            (WHNP-1 (-NONE- 0) )
            (S 
              (NP-SBJ (JJ surgical) (NNS patients) )
              (VP (MD can) 
                (VP (VB donate) 
                  (CC and)
                  (VB store) 
                  (NP (-NONE- *T*-1) )
                  (PP-TMP (IN before) 
                    (NP (NN surgery) )))))))))
    (VP (MD can) 
      (VP (VB be) 
        (VP (VBN increased) 
          (NP (-NONE- *-3) )
          (PP (IN by) 
            (NP-LGS 
              (NP (DT the) (JJ new) 
                (ADJP (RB genetically) (VBN engineered) )
                (NN drug) )
              (, ,) 
              (NP (NNP EPO) ))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NNP EPO) )
      (, ,) (CC or) 
      (NP (NN erythropoietin) )
      (, ,) )
    (VP (VBZ is) 
      (NP-PRD 
        (NP (DT a) (NN protein) )
        (SBAR 
          (WHNP-1 (-NONE- 0) )
          (S 
            (NP-SBJ-2 (DT the) (JJ human) (NN body) )
            (VP (VBZ makes) 
              (NP (-NONE- *T*-1) )
              (S-PRP 
                (NP-SBJ (-NONE- *-2) )
                (VP (TO to) 
                  (VP (VB stimulate) 
                    (NP 
                      (NP (DT the) (NN growth) )
                      (PP (IN of) 
                        (NP (JJ red) (NN blood) (NNS cells) )))))))))))
    (. .) ))
( (S 
    (NP-SBJ-1 
      (NP (DT A) 
        (ADJP (RB genetically) (VBN engineered) )
        (NN version) )
      (PP (IN of) 
        (NP (DT the) (JJ human) (NN protein) ))
      (VP (VBN developed) 
        (NP (-NONE- *) )
        (PP (IN by) 
          (NP-LGS 
            (NP (NNP Amgen) (NNP Corp.) )
            (PP (IN of) 
              (NP 
                (NP (NNP Thousand) (NNP Oaks) )
                (, ,) 
                (NP (NNP Calif.) )
                (, ,) ))))))
    (ADVP-TMP (RB recently) )
    (VP (VBZ has) 
      (VP (VBN been) 
        (VP (VBN marketed) 
          (NP (-NONE- *-1) )
          (PP (IN by) 
            (NP-LGS 
              (NP (DT the) (NNP Ortho) (NNP Pharmaceuticals) (NN division) )
              (PP (IN of) 
                (NP (NNP Johnson) (CC &) (NNP Johnson) )))))))
    (. .) ))
( (S 
    (NP-SBJ-1 
      (NP (DT A) (VBG competing) (NN version) )
      (PP (IN of) 
        (NP (NNP EPO) )))
    (VP (VBZ is) 
      (VP (VBG being) 
        (VP (VBN developed) 
          (NP (-NONE- *-1) )
          (PP (IN by) 
            (NP-LGS 
              (NP (NNP Genetics) (NNP Institute) (NNP Inc.) )
              (PP-LOC (IN in) 
                (NP 
                  (NP (NNP Cambridge) )
                  (, ,) 
                  (NP (NNP Mass) ))))))))
    (. .) ))
( (S 
    (NP-SBJ-1 (DT The) (NN drug) )
    (VP (VBZ is) 
      (VP (VBG being) 
        (VP (VBN used) 
          (NP (-NONE- *-1) )
          (ADVP (RB primarily) )
          (S-CLR 
            (NP-SBJ (-NONE- *) )
            (VP (TO to) 
              (VP (VB treat) 
                (NP (NNS anemias) )))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (DT A) (JJ new) (NN experiment) )
      (, ,) 
      (VP (VBN reported) 
        (NP (-NONE- *) )
        (PP-LOC (IN in) 
          (NP 
            (NP 
              (NP (DT this) (NN week) (POS 's) )
              (NNP New) (NNP England) (NNP Journal) )
            (PP (IN of) 
              (NP (NNP Medicine) )))))
      (, ,) )
    (VP (VBD involved) 
      (S 
        (NP-SBJ (-NONE- *) )
        (VP (VBG giving) 
          (NP 
            (NP (NNS injections) )
            (PP (IN of) 
              (NP 
                (NP (NNP Amgen) (POS 's) )
                (NNP EPO) )))
          (PP-DTV (TO to) 
            (NP 
              (NP (CD 23) (NNS patients) )
              (SBAR 
                (WHNP-1 (WP who) )
                (S 
                  (NP-SBJ-2 (-NONE- *T*-1) )
                  (VP (VBD wanted) 
                    (S 
                      (NP-SBJ (-NONE- *-2) )
                      (VP (TO to) 
                        (VP (VB store) 
                          (NP 
                            (NP (NNS units) )
                            (PP (IN of) 
                              (NP (PRP$ their) (JJ own) (NN blood) ))))))))))))))
    (. .) ))
( (S 
    (NP-SBJ-1 (DT The) (NNS patients) )
    (VP (VBD began) 
      (S 
        (NP-SBJ (-NONE- *-1) )
        (VP (VBG receiving) 
          (NP (NNP EPO) (NNS injections) )
          (PP-TMP 
            (NP-ADV 
              (QP (IN about) (DT a) )
              (NN month) )
            (IN before) 
            (NP (PRP$ their) (VBN scheduled) (NN surgery) )))))
    (. .) ))
( (S 
    (NP-SBJ-1 (PRP They) )
    (ADVP-TMP (RB then) )
    (VP (VBD began) 
      (S 
        (NP-SBJ-2 (-NONE- *-1) )
        (VP (VBG donating) 
          (NP (NN blood) )
          (NP-TMP (RB twice) (DT a) (NN week) )
          (, ,) 
          (S-ADV 
            (NP-SBJ (-NONE- *-2) )
            (VP (VBG receiving) 
              (NP (DT an) (NNP EPO) (NN injection) )
              (NP-TMP (DT each) (NN time) ))))))
    (. .) ))
( (S 
    (SBAR-ADV (IN If) 
      (S 
        (NP-SBJ (NNS tests) )
        (VP (VBD indicated) 
          (NP 
            (NP (DT a) (JJ low) (NN number) )
            (PP (IN of) 
              (NP (JJ red) (NNS cells) ))))))
    (, ,) 
    (NP-SBJ-1 (NN blood) )
    (VP (VBD was) (RB n't) 
      (VP (VBN taken) 
        (NP (-NONE- *-1) )))
    (. .) ))
( (S 
    (NP-SBJ (DT The) (JJ EPO-treated) (NNS patients) )
    (VP (VBD donated) 
      (NP 
        (NP (DT an) (NN average) )
        (PP (IN of) 
          (NP 
            (NP (CD 5.4) (NNS units) )
            (PP (IN of) 
              (NP (NN blood) ))))
        (NP-ADV (DT each) ))
      (PP (VBN compared) 
        (PP (IN with) 
          (NP 
            (NP 
              (QP (RB only) (CD 4.1) )
              (NNS units) )
            (VP (VBN donated) 
              (NP (-NONE- *) )
              (PP (IN by) 
                (NP-LGS 
                  (NP (DT a) (JJ similar) (NN group) )
                  (PP (IN of) 
                    (NP 
                      (NP (JJ surgical) (NNS patients) )
                      (SBAR 
                        (WHNP-1 (WP who) )
                        (S 
                          (NP-SBJ (-NONE- *T*-1) )
                          (VP (VBD received) 
                            (NP (DT a) (NN placebo) (NN injection) )))))))))))))
    (. .) ))
( (S 
    (S-TPC-1 
      (NP-SBJ 
        (NP (DT The) (NN volume) )
        (PP (IN of) 
          (NP 
            (NP (JJ red) (NNS cells) )
            (VP (VBN donated) 
              (NP (-NONE- *) )
              (PP (IN by) 
                (NP-LGS (DT the) (JJ EPO-treated) (NNS patients) ))))))
      (VP (VBD was) 
        (ADVP-PRD 
          (NP (CD 41) (NN %) )
          (JJR higher) )
        (PP (IN per) 
          (NP (NN donor) ))))
    (, ,) 
    (NP-SBJ 
      (NP (DT the) (NN research) (NN team) )
      (VP (VBG representing) 
        (NP 
          (NP (DT a) (NN number) )
          (PP (IN of) 
            (NP 
              (NP (NNS hospitals) )
              (CC and) 
              (NP (NN blood) (NNS banks) ))))))
    (VP (VBD reported) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (. .) ))
